{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T16:42:20Z","timestamp":1773160940976,"version":"3.50.1"},"reference-count":150,"publisher":"Georg Thieme Verlag KG","issue":"03","funder":[{"DOI":"10.13039\/501100001700","name":"the Japanese Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"crossref","award":["MEXT; 16K09820"],"award-info":[{"award-number":["MEXT; 16K09820"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"the Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["AMED; 16ek0109043h0003"],"award-info":[{"award-number":["AMED; 16ek0109043h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Japanese Ministry of Health, Labor, and Welfare","award":["MHLW; 21FC1008"],"award-info":[{"award-number":["MHLW; 21FC1008"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Thromb Hemost"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Coagulation factor XIII (FXIII) is an essential protein that stabilizes the hemostatic plug formed in the final stage of the coagulation reaction and controls its dissolution. In the blood, it exists as a heterotetramer consisting of A subunit dimers and B subunit dimers. Genetic defects in each subunit result in a congenital deficiency, which causes fatal or mild bleeding symptoms. Acquired FXIII deficiency can develop owing to reduced production or increased consumption of FXIII, and its severe form can cause various bleeding symptoms. In particular, autoimmune FXIII deficiency (AiF13D) causes fatal bleeding symptoms due to the suppression of FXIII activity by anti-FXIII autoantibodies and\/or accelerated clearance of FXIII. AiF13D is characterized by extremely severe FXIII deficiency and severe bleeding symptoms. It is associated with the highest hemorrhagic mortality rate among autoimmune coagulation factor deficiencies, making it essential to differentiate it from other non-immune FXIII deficiencies (NiF13D), such as those arising from liver cirrhosis or leukemia. The probable and definitive diagnosis of AiF13D require the presence of FXIII inhibitors and anti-FXIII autoantibodies, respectively. FXIII inhibitors can be detected by a general FXIII activity assay in the mixed plasma of patients and healthy controls, and can be measured in a regular laboratory. In contrast, immunological assays are conducted in limited research facilities because they are not commercially available. NiF13D is usually treated by hemostatic therapy with FXIII concentrates, but AiF13D requires hemostatic therapy plus autoantibody eradication therapy with immunosuppressants. Since the disease often becomes resistant to treatment, long-term follow-up is strongly recommended.<\/jats:p>","DOI":"10.1055\/a-2633-0027","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T19:47:12Z","timestamp":1749757632000},"page":"280-303","source":"Crossref","is-referenced-by-count":2,"title":["Immune-Related and Non-Immune-Related Acquired Factor XIII Deficiency"],"prefix":"10.1055","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3807-5628","authenticated-orcid":false,"given":"Akitada","family":"Ichinose","sequence":"additional","affiliation":[{"name":"Department of Molecular Patho-Biochemistry and Patho-Biology, Yamagata University School of Medicine, Yamagata, Japan"},{"name":"The Japanese Collaborative Research Group (JCRG) on Autoimmune Acquired Coagulation Factor Deficiencies supported by the Japanese Ministry of Health, Labor and Welfare (MHLW), Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"issue":"06","key":"ref1","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/0006-291X(66)90562-6","article-title":"Transglutaminase as a blood clotting enzyme","volume":"23","author":"J B Lorand","year":"1966","journal-title":"Biochem Biophys Res Commun"},{"issue":"01","key":"ref2","first-page":"57","article-title":"Physiopathology and regulation of factor XIII","volume":"86","author":"A Ichinose","year":"2001","journal-title":"Thromb Haemost"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1749-6632.2001.tb03516.x","article-title":"Factor XIII: structure, activation, and interactions with fibrinogen and fibrin","volume":"936","author":"L Lorand","year":"2001","journal-title":"Ann N Y Acad Sci"},{"issue":"01","key":"ref4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3181\/00379727-89-21711","article-title":"Assay method for the fibrin-stabilizing factor","volume":"89","author":"L Lorand","year":"1955","journal-title":"Proc Soc Exp Biol Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1126\/science.108.2802.280","article-title":"On the solubility of fibrin clots","volume":"108","author":"K Laki","year":"1948","journal-title":"Science"},{"issue":"02","key":"ref6","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0021-9258(18)71170-8","article-title":"Studies on the formation of urea-insoluble fibrin","volume":"211","author":"A G Loewy","year":"1954","journal-title":"J Biol Chem"},{"issue":"06","key":"ref7","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1172\/JCI106061","article-title":"Diagnostic and genetic studies on fibrin-stabilizing factor with a new assay based on amine incorporation","volume":"48","author":"L Lorand","year":"1969","journal-title":"J Clin Invest"},{"key":"ref8","first-page":"2625","article-title":"Fibrinase. I. Purification of substrate and enzyme","volume":"236","author":"A G Loewy","year":"1961","journal-title":"J Biol Chem"},{"issue":"01","key":"ref9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1538-7836.2006.02182.x","article-title":"Factor XIII: recommended terms and abbreviations","volume":"5","author":"L Muszbek","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"18","key":"ref10","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.1016\/S0021-9258(18)61888-5","article-title":"The subunit structures of human plasma and platelet factor XIII (fibrin-stabilizing factor)","volume":"246","author":"M L Schwartz","year":"1971","journal-title":"J Biol Chem"},{"issue":"01","key":"ref11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s12185-007-0005-z","article-title":"Administration of factor XIII B subunit increased plasma factor XIII A subunit levels in factor XIII B subunit knock-out mice","volume":"87","author":"M Souri","year":"2008","journal-title":"Int J Hematol"},{"issue":"05","key":"ref12","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1182\/blood.2023022042","article-title":"Reciprocal stabilization of coagulation factor XIII-A and -B subunits is a determinant of plasma FXIII concentration","volume":"143","author":"J R Byrnes","year":"2024","journal-title":"Blood"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1182\/blood-2013-10-533596","article-title":"Interaction of factor XIII subunits","volume":"123","author":"E Katona","year":"2014","journal-title":"Blood"},{"issue":"04","key":"ref14","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s12185-012-1064-3","article-title":"Factor XIII is a key molecule at the intersection of coagulation and fibrinolysis as well as inflammation and infection control","volume":"95","author":"A Ichinose","year":"2012","journal-title":"Int J Hematol"},{"issue":"S 02","key":"ref15","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/j.thromres.2012.02.040","article-title":"Factor XIII and inflammatory cells","volume":"129","author":"Z Bagoly","year":"2012","journal-title":"Thromb Res"},{"issue":"16","key":"ref16","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1021\/bi00364a027","article-title":"Amino acid sequence of the b subunit of human factor XIII, a protein composed of ten repetitive segments","volume":"25","author":"A Ichinose","year":"1986","journal-title":"Biochemistry"},{"issue":"22","key":"ref17","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.1021\/bi00370a025","article-title":"Amino acid sequence of the a subunit of human factor XIII","volume":"25","author":"A Ichinose","year":"1986","journal-title":"Biochemistry"},{"issue":"05","key":"ref18","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/oxfordjournals.jbchem.a021336","article-title":"Expression and release of the a and b subunits for human coagulation factor XIII in baby hamster kidney (BHK) cells","volume":"119","author":"H Kaetsu","year":"1996","journal-title":"J Biochem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000084241","article-title":"Extracellular transglutaminase: factor XIII","volume":"38","author":"A Ichinose","year":"2005","journal-title":"Prog Exp Tumor Res"},{"issue":"23","key":"ref20","doi-asserted-by":"crossref","first-page":"13411","DOI":"10.1016\/S0021-9258(18)77358-4","article-title":"Structure of transglutaminases","volume":"265","author":"A Ichinose","year":"1990","journal-title":"J Biol Chem"},{"issue":"15","key":"ref21","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1073\/pnas.91.15.7296","article-title":"Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII","volume":"91","author":"V C Yee","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"05","key":"ref22","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/jth.14412","article-title":"Factor XIII topology: organization of B subunits and changes with activation studied with single-molecule atomic force microscopy","volume":"17","author":"A D Protopopova","year":"2019","journal-title":"J Thromb Haemost"},{"issue":"04","key":"ref23","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1182\/blood.2024025369","article-title":"Cryo-EM structure of the human native plasma coagulation factor XIII complex","volume":"145","author":"S Singh","year":"2025","journal-title":"Blood"},{"issue":"01","key":"ref24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000132580","article-title":"Localization of the coagulation factor XIII A subunit gene (F13A) to chromosome bands 6p24\u2014-p25","volume":"48","author":"P G Board","year":"1988","journal-title":"Cytogenet Cell Genet"},{"issue":"16","key":"ref25","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1073\/pnas.85.16.5829","article-title":"Characterization of the gene for the a subunit of human factor XIII (plasma transglutaminase), a blood coagulation factor","volume":"85","author":"A Ichinose","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"ref26","doi-asserted-by":"crossref","first-page":"6138","DOI":"10.1074\/jbc.274.10.6138","article-title":"Transcriptional regulation of cell type-specific expression of the TATA-less A subunit gene for human coagulation factor XIII","volume":"274","author":"M Kida","year":"1999","journal-title":"J Biol Chem"},{"issue":"03","key":"ref27","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1055\/s-0037-1614929","article-title":"Novel deletion and insertion mutations cause splicing defects, leading to severe reduction in mRNA levels of the A subunit in severe factor XIII deficiency","volume":"79","author":"T Izumi","year":"1998","journal-title":"Thromb Haemost"},{"issue":"06","key":"ref28","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/jhg.2011.41","article-title":"Homozygous intronic mutation leading to inefficient transcription combined with a novel frameshift mutation in F13A1 gene causes FXIII deficiency","volume":"56","author":"W Wang","year":"2011","journal-title":"J Hum Genet"},{"issue":"01","key":"ref29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0167-4838(94)00167-F","article-title":"Biosynthesis of plasma factor XIII: evidence for transcription and translation in hepatoma cells","volume":"1247","author":"E Kaczmarek","year":"1995","journal-title":"Biochim Biophys Acta"},{"issue":"08","key":"ref30","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1161\/ATVBAHA.117.309271","article-title":"Cre\/lox studies identify resident macrophages as the major source of circulating coagulation factor XIII-A","volume":"37","author":"C ML Beckers","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"02","key":"ref31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF00293893","article-title":"Localization of the coagulation factor XIII B subunit gene (F13B) to chromosome bands 1q31-32.1 and restriction fragment length polymorphism at the locus","volume":"81","author":"G C Webb","year":"1989","journal-title":"Hum Genet"},{"issue":"06","key":"ref32","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/BF00355378","article-title":"Coagulation factor XIII B subunit is encoded by a gene linked to the regulator of complement activation (RCA) gene cluster in man","volume":"28","author":"S Rodriguez de Cordoba","year":"1988","journal-title":"Immunogenetics"},{"issue":"51","key":"ref33","doi-asserted-by":"crossref","first-page":"11195","DOI":"10.1021\/bi00503a007","article-title":"Nucleotide sequence of the gene for the b subunit of human factor XIII","volume":"29","author":"R E Bottenus","year":"1990","journal-title":"Biochemistry"},{"issue":"04","key":"ref34","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00109-005-0013-5","article-title":"Role of hepatocyte nuclear factor 4alpha in control of blood coagulation factor gene expression","volume":"84","author":"Y Inoue","year":"2006","journal-title":"J Mol Med (Berl)"},{"issue":"07","key":"ref35","first-page":"1065","article-title":"[Pathophysiology of coagulation in the newborn infant] [in Japanese]","volume":"28","author":"A Shirahata","year":"1987","journal-title":"Rinsho Ketsueki"},{"issue":"01","key":"ref36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1182\/blood.V70.1.165.165","article-title":"Development of the human coagulation system in the full-term infant","volume":"70","author":"M Andrew","year":"1987","journal-title":"Blood"},{"issue":"04","key":"ref37","first-page":"469","article-title":"[Studies on the physiological changes of blood coagulation factor XIII during pregnancy and their significance (author's transl)] [in Japanese]","volume":"34","author":"Y Hayano","year":"1982","journal-title":"Nippon Sanka Fujinka Gakkai Zasshi"},{"issue":"05","key":"ref39","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1055\/s-2007-999036","article-title":"The normal and abnormal genes of the a and b subunits in coagulation factor XIII","volume":"22","author":"A Ichinose","year":"1996","journal-title":"Semin Thromb Hemost"},{"key":"ref40","first-page":"179","article-title":"A hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilizing factor deficiency","volume":"5","author":"F Duckert","year":"1960","journal-title":"Thromb Diath Haemorrh"},{"issue":"07","key":"ref41","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1111\/j.1538-7836.2011.04315.x","article-title":"Diagnosis and classification of factor XIII deficiencies","volume":"9","author":"H P Kohler","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"03","key":"ref42","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1365-2141.1990.00282.x-i1","article-title":"A familial factor XIII subunit B deficiency","volume":"74","author":"M Saito","year":"1990","journal-title":"Br J Haematol"},{"issue":"13","key":"ref43","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1182\/blood-2003-05-1467","article-title":"Factor XIII A subunit-deficient mice developed severe uterine bleeding events and subsequent spontaneous miscarriages","volume":"102","author":"S Koseki-Kuno","year":"2003","journal-title":"Blood"},{"issue":"02","key":"ref44","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1172\/JCI115864","article-title":"Deficiency of coagulation factor XIII A subunit caused by the dinucleotide deletion at the 5\u2032 end of exon III","volume":"90","author":"T Kamura","year":"1992","journal-title":"J Clin Invest"},{"issue":"01","key":"ref45","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood.V82.1.145.bloodjournal821145","article-title":"Two genetic defects in a patient with complete deficiency of the b-subunit for coagulation factor XIII","volume":"82","author":"T Hashiguchi","year":"1993","journal-title":"Blood"},{"issue":"01","key":"ref46","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1160\/TH05-06-0388","article-title":"Characterisation of six novel A-subunit mutations leading to congenital factor XIII deficiency and molecular analysis of the first diagnosed patient with this rare bleeding disorder","volume":"95","author":"V Schroeder","year":"2006","journal-title":"Thromb Haemost"},{"issue":"03","key":"ref47","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1172\/JCI117744","article-title":"Molecular and cellular basis of deficiency of the b subunit for factor XIII secondary to a Cys430-Phe mutation in the seventh Sushi domain","volume":"95","author":"T Hashiguchi","year":"1995","journal-title":"J Clin Invest"},{"issue":"09","key":"ref48","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1182\/blood.V97.9.2667","article-title":"Truncated mutant B subunit for factor XIII causes its deficiency due to impaired intracellular transportation","volume":"97","author":"S Koseki","year":"2001","journal-title":"Blood"},{"issue":"03","key":"ref49","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/hae.12072","article-title":"Proteosomal degradation of naturally recurring R260C missense and exon-IV deletion mutants of factor XIII A-subunit expressed in mammalian cells","volume":"19","author":"W G Zhang","year":"2013","journal-title":"Haemophilia"},{"issue":"04","key":"ref50","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1538-7836.2012.04653.x","article-title":"Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders","volume":"10","author":"F Peyvandi","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"09","key":"ref51","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1111\/jth.13772","article-title":"Minimal factor XIII activity level to prevent major spontaneous bleeds","volume":"15","author":"M Menegatti","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"05","key":"ref52","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1055\/s-2007-999040","article-title":"ETRO Working Party on Factor XIII questionnaire on congenital factor XIII deficiency in Europe: status and perspectives","volume":"22","author":"R Seitz","year":"1996","journal-title":"Semin Thromb Hemost"},{"issue":"06","key":"ref53","doi-asserted-by":"crossref","first-page":"956","DOI":"10.3324\/haematol.2009.017210","article-title":"Identification of eight novel coagulation factor XIII subunit A mutations: implied consequences for structure and function","volume":"95","author":"V Ivaskevicius","year":"2010","journal-title":"Haematologica"},{"issue":"02","key":"ref54","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-0043-1764471","article-title":"Novel insights into heterozygous factor XIII deficiency","volume":"50","author":"A Dorgalaleh","year":"2024","journal-title":"Semin Thromb Hemost"},{"issue":"09","key":"ref55","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.3324\/haematol.2010.028969","article-title":"Bleeding symptoms in heterozygous factor XIII [corrected] deficiency","volume":"95","author":"P M Mannucci","year":"2010","journal-title":"Haematologica"},{"issue":"06","key":"ref56","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/hae.12503","article-title":"Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project","volume":"20","author":"M Elbatarny","year":"2014","journal-title":"Haemophilia"},{"issue":"02","key":"ref57","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jtha.2023.09.032","article-title":"Heterozygosity in factor XIII genes and the manifestation of mild inherited factor XIII deficiency","volume":"22","author":"S Singh","year":"2024","journal-title":"J Thromb Haemost"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1182\/blood.V23.5.669.669","article-title":"Plasma fibrin stabilizing factor activity in various diseases","volume":"23","author":"M Nussbaum","year":"1964","journal-title":"Blood"},{"issue":"05","key":"ref59","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/ajcp\/52.5.547","article-title":"Plasma fibrin-stabilizing factor: acquired deficiency in various disorders","volume":"52","author":"E E Mandel","year":"1969","journal-title":"Am J Clin Pathol"},{"issue":"06","key":"ref60","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.transci.2018.10.013","article-title":"Acquired factor XIII deficiency: a review","volume":"57","author":"M TS Yan","year":"2018","journal-title":"Transfus Apher Sci"},{"issue":"04","key":"ref61","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1055\/s-0031-1276587","article-title":"Hemorrhagic acquired factor XIII (13) deficiency and acquired hemorrhaphilia 13 revisited","volume":"37","author":"A Ichinose","year":"2011","journal-title":"Semin Thromb Hemost"},{"issue":"01","key":"ref62","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11239-012-0818-3","article-title":"Acquired FXIII inhibitors: a systematic review","volume":"36","author":"M Franchini","year":"2013","journal-title":"J Thromb Thrombolysis"},{"issue":"01","key":"ref63","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.blre.2016.08.002","article-title":"Autoimmune acquired factor XIII deficiency due to anti-factor XIII\/13 antibodies: a summary of 93 patients","volume":"31","author":"A Ichinose","year":"2017","journal-title":"Blood Rev"},{"issue":"05","key":"ref64","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1055\/s-0044-1787188","article-title":"Diagnosis and treatment of autoimmune acquired coagulation factor deficiencies: an evidence-based review of Japanese practice","volume":"51","author":"A Ichinose","year":"2025","journal-title":"Semin Thromb Hemost"},{"issue":"05","key":"ref65","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/jth.12877","article-title":"Anti-factor XIII A subunit (FXIII-A) autoantibodies block FXIII-A2 B2 assembly and steal FXIII-A from native FXIII-A2 B2","volume":"13","author":"M Souri","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"03","key":"ref66","doi-asserted-by":"crossref","first-page":"103654","DOI":"10.1016\/j.transci.2023.103654","article-title":"Perioperative therapeutic plasma exchange in a patient with rare factor XIII inhibitor","volume":"62","author":"J Smith","year":"2023","journal-title":"Transfus Apher Sci"},{"issue":"05","key":"ref67","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/clinchem\/34.5.906","article-title":"Colorimetric assay of blood coagulation factor XIII in plasma","volume":"34","author":"K N Lee","year":"1988","journal-title":"Clin Chem"},{"issue":"04","key":"ref68","first-page":"704","article-title":"A common coding polymorphism in the FXIII A-subunit gene (FXIIIVal34Leu) affects cross-linking activity","volume":"80","author":"H P Kohler","year":"1998","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref69","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s12185-024-03807-y","article-title":"Detection of factor XIII inhibitors in 33 patients with autoimmune factor XIII deficiency in Japan","volume":"120","author":"M Souri","year":"2024","journal-title":"Int J Hematol"},{"issue":"02","key":"ref70","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0014-5793(83)80645-0","article-title":"Factor XIII-mediated cross-linking of NH2-terminal peptide of alpha 2-plasmin inhibitor to fibrin","volume":"153","author":"A Ichinose","year":"1983","journal-title":"FEBS Lett"},{"issue":"02","key":"ref71","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/0167-4838(82)90482-4","article-title":"Reversible cross-linking of alpha 2-plasmin inhibitor to fibrinogen by fibrin-stabilizing factor","volume":"706","author":"A Ichinose","year":"1982","journal-title":"Biochim Biophys Acta"},{"issue":"03","key":"ref72","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3390\/ijms22031002","article-title":"Clinical validation of an automated fluorogenic factor XIII activity assay based on isopeptidase activity","volume":"22","author":"M Leitner","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jfma.2020.05.032","article-title":"Acquired FXIII inhibitor: patient characteristics and treatment outcome, a case series in Taiwan","volume":"120","author":"S C Chou","year":"2021","journal-title":"J Formos Med Assoc"},{"issue":"08","key":"ref74","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/jth.13367","article-title":"Neutralizing autoantibody against factor XIII A subunit resulted in severe bleeding diathesis with a fatal outcome\u2014characterization of the antibody","volume":"14","author":"K P\u00e9nzes","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"06","key":"ref75","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/jth.14811","article-title":"Autoimmune factor XIII deficiency with unusual laboratory and clinical phenotype","volume":"18","author":"J Bovet","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"03","key":"ref76","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/hae.14298","article-title":"Pathological coagulation parameters in as many as 54 patients with autoimmune acquired factor XIII deficiency due to anti-factor XIII autoantibodies","volume":"27","author":"A Ichinose","year":"2021","journal-title":"Haemophilia"},{"issue":"03","key":"ref77","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1182\/blood-2008-09-179333","article-title":"Severe bleeding complications caused by an autoantibody against the B subunit of plasma factor XIII: a novel form of acquired factor XIII deficiency","volume":"113","author":"E Ajzner","year":"2009","journal-title":"Blood"},{"issue":"06","key":"ref78","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1160\/TH14-09-0745","article-title":"Rapid immunochromatographic test for detection of anti-factor XIII A subunit antibodies can diagnose 90\u2009% of cases with autoimmune haemorrhaphilia XIII\/13","volume":"113","author":"T Osaki","year":"2015","journal-title":"Thromb Haemost"},{"issue":"08","key":"ref79","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1055\/a-2061-3182","article-title":"Novel immunochromatographic test for anti-factor XIII B subunit autoantibodies to diagnose autoimmune acquired factor XIII deficiency","volume":"123","author":"T Osaki","year":"2023","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref80","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1160\/TH16-05-0362","article-title":"Recommendation for ISTH\/SSC Criterion 2015 for autoimmune acquired factor XIII\/13 deficiency","volume":"116","author":"A Ichinose","year":"2016","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref81","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1046\/j.1468-0734.2001.00049.x","article-title":"Acquired hemophilia","volume":"5","author":"L N Boggio","year":"2001","journal-title":"Rev Clin Exp Hematol"},{"issue":"05","key":"ref82","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1055\/s-0032-1305779","article-title":"Acquired inhibitors of coagulation factors: part II","volume":"38","author":"M Franchini","year":"2012","journal-title":"Semin Thromb Hemost"},{"issue":"01","key":"ref83","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.autrev.2013.08.001","article-title":"Autoantibodies to coagulation factors: from pathophysiology to diagnosis and therapy","volume":"13","author":"M Cugno","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"06","key":"ref84","first-page":"401","article-title":"An acquired inhibitor to coagulation factor 13","volume":"120","author":"J H Lewis","year":"1967","journal-title":"Johns Hopkins Med J"},{"issue":"05","key":"ref85","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1111\/hae.14613","article-title":"Autoimmune acquired factor XIII deficiency in Japan 2021 update: focused on annual incidence and clinical features","volume":"28","author":"A Ichinose","year":"2022","journal-title":"Haemophilia"},{"issue":"05","key":"ref86","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s12185-022-03301-3","article-title":"Plasma proteomics associated with autoimmune coagulation factor deficiencies reveals the link between inflammation and autoantibody development","volume":"115","author":"T Osaki","year":"2022","journal-title":"Int J Hematol"},{"issue":"02","key":"ref87","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ajh.26426","article-title":"First and fatal case of autoimmune acquired factor XIII\/13 deficiency after COVID-19\/SARS-CoV-2 vaccination","volume":"97","author":"S Shimoyama","year":"2022","journal-title":"Am J Hematol"},{"issue":"10","key":"ref88","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1055\/a-1863-7265","article-title":"Autoimmune acquired factor XIII\/13 deficiency after SARS-CoV-2 mRNA vaccination","volume":"122","author":"S Nakamura","year":"2022","journal-title":"Thromb Haemost"},{"issue":"09","key":"ref89","doi-asserted-by":"crossref","first-page":"e0257322","DOI":"10.1371\/journal.pone.0257322","article-title":"Important roles of the human leukocyte antigen class I and II molecules and their associated genes in the autoimmune coagulation factor XIII deficiency via whole-exome sequencing analysis","volume":"16","author":"T Osaki","year":"2021","journal-title":"PLoS One"},{"issue":"02","key":"ref90","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jtha.2022.11.019","article-title":"Cloning of human anti-factor XIII monoclonal antibody dissects mechanisms of polyclonal antibodies in a single patient","volume":"21","author":"M Souri","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"09","key":"ref91","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/1873-3468.14606","article-title":"Epitope analysis of human monoclonal antibodies from a patient with autoimmune factor XIII deficiency reveals their inhibitory mechanisms","volume":"597","author":"T Osaki","year":"2023","journal-title":"FEBS Lett"},{"issue":"02","key":"ref92","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s12185-024-03874-1","article-title":"A case of autoimmune factor XIII deficiency due to clearance-accelerating and inhibitory anti-FXIII autoantibodies","volume":"121","author":"H Tsunemine","year":"2025","journal-title":"Int J Hematol"},{"issue":"09","key":"ref93","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1111\/j.1538-7836.2010.03975.x","article-title":"ISTH\/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders","volume":"8","author":"F Rodeghiero","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"06","key":"ref94","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1055\/s-0034-1390151","article-title":"Inhibitors of factor XIII\/13 in older patients","volume":"40","author":"A Ichinose","year":"2014","journal-title":"Semin Thromb Hemost"},{"issue":"11","key":"ref95","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1111\/j.1538-7836.2010.04028.x","article-title":"Factor XIII\u2014an under diagnosed deficiency\u2014are we using the right assays?","volume":"8","author":"A S Lawrie","year":"2010","journal-title":"J Thromb Haemost"},{"key":"ref96","first-page":"10","article-title":"Mild acquired factor XIII deficiency and clinical relevance at the ICU\u2014a retrospective analysis","volume":"27","author":"F CF Schmitt","year":"2021","journal-title":"Clin Appl Thromb Hemost"},{"issue":"02","key":"ref97","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/liv.15132","article-title":"Fibrin clot quality in acutely ill cirrhosis patients: relation with outcome and improvement with coagulation factor concentrates","volume":"42","author":"A Blasi","year":"2022","journal-title":"Liver Int"},{"issue":"04","key":"ref98","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1055\/s-2007-1004394","article-title":"A contribution to the pathology of acquired plasma factor XIII deficiency","volume":"11","author":"G Ballerini","year":"1985","journal-title":"Semin Thromb Hemost"},{"issue":"04","key":"ref99","first-page":"539","article-title":"Fibrin stabilization, factor XIII transamidase activity and subunits \u201cA\u201d and \u201cB\u201d concentration in plasma of patients with liver cirrhosis","volume":"113","author":"J K\u0142oczko","year":"1986","journal-title":"Folia Haematol Int Mag Klin Morphol Blutforsch"},{"issue":"25","key":"ref100","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1182\/blood.2020004976","article-title":"Sustained depletion of FXIII-A by inducing acquired FXIII-B deficiency","volume":"136","author":"A W Strilchuk","year":"2020","journal-title":"Blood"},{"issue":"03","key":"ref101","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1055\/s-0038-1646739","article-title":"Quantitative estimation of coagulation factors in liver disease. The diagnostic and prognostic value of factor XIII, factor V and plasminogen","volume":"39","author":"L Biland","year":"1978","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref102","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1478-3231.2005.01205.x","article-title":"Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease","volume":"26","author":"F Tacke","year":"2006","journal-title":"Liver Int"},{"issue":"31","key":"ref103","first-page":"194","article-title":"Reduced levels of coagulation factor XIII in patients with advanced tumor disease","volume":"47","author":"P Born","year":"2000","journal-title":"Hepatogastroenterology"},{"issue":"04","key":"ref104","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000181784","article-title":"Coagulation factor XIII in patients with acute and chronic renal disease","volume":"25","author":"F Carmassi","year":"1980","journal-title":"Nephron J"},{"issue":"10","key":"ref105","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.dld.2019.03.011","article-title":"Acute kidney injury is associated with low factor XIII in decompensated cirrhosis","volume":"51","author":"N M Intagliata","year":"2019","journal-title":"Dig Liver Dis"},{"issue":"04","key":"ref106","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/hep.31443","article-title":"Acute kidney injury in decompensated cirrhosis is associated with both hypo-coagulable and hyper-coagulable features","volume":"72","author":"A Zanetto","year":"2020","journal-title":"Hepatology"},{"issue":"07","key":"ref107","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s00277-023-05261-y","article-title":"Reduced plasma coagulation factor XIII in patients with acute leukemia in remission during consolidation chemotherapy cycles","volume":"102","author":"X Y Lv","year":"2023","journal-title":"Ann Hematol"},{"issue":"06","key":"ref108","first-page":"874","article-title":"Fibrin stabilizing factor (factor XIII) consumption as an indicator of disseminated intravascular coagulation (DIC)","volume":"104","author":"A Zuch","year":"1977","journal-title":"Folia Haematol Int Mag Klin Morphol Blutforsch"},{"issue":"11","key":"ref109","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.2169\/naika.70.1531","article-title":"[Disseminated intravascular coagulation (DIC); findings in 40 patients (author's transl)] [in Japanese]","volume":"70","author":"A Ichinose","year":"1981","journal-title":"Nihon Naika Gakkai Zasshi"},{"issue":"11","key":"ref110","first-page":"2300","article-title":"[Successful treatment of chronic disseminated intravascular coagulation using recombinant human soluble thrombomodulin in a dialysis patient with dissecting aortic aneurysm] [in Japanese]","volume":"55","author":"K Hayakawa","year":"2014","journal-title":"Rinsho Ketsueki"},{"issue":"06","key":"ref111","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/MBC.0b013e32835facef","article-title":"Severe inhibitor-negative acquired factor XIII\/13 deficiency with aggressive subdural haemorrhage","volume":"24","author":"H Kawano","year":"2013","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"S 01","key":"ref112","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1055\/s-0037-1619795","article-title":"Relevant bleeding diathesis due to acquired factor XIII deficiency","volume":"33","author":"M Janning","year":"2013","journal-title":"Hamostaseologie"},{"issue":"03","key":"ref113","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1651-2227.1977.tb07893.x","article-title":"Factor XIII (fibrin stabilising factor) in Henoch-Sch\u00f6nlein's purpura","volume":"66","author":"P Henriksson","year":"1977","journal-title":"Acta Paediatr Scand"},{"issue":"05","key":"ref114","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/BF00441608","article-title":"Activity of blood coagulation factor XIII as a prognostic indicator in patients with Henoch-Sch\u00f6nlein purpura. Efficacy of factor XIII substitution","volume":"146","author":"H Kamitsuji","year":"1987","journal-title":"Eur J Pediatr"},{"issue":"05","key":"ref115","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1055\/s-2007-999041","article-title":"Factor XIII deficiency: pathogenic mechanisms and clinical significance","volume":"22","author":"R Egbring","year":"1996","journal-title":"Semin Thromb Hemost"},{"issue":"04","key":"ref116","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2257.1983.tb00516.x","article-title":"Reduced levels of factor XIII in patients with chronic inflammatory bowel disease","volume":"5","author":"M J Galloway","year":"1983","journal-title":"Clin Lab Haematol"},{"issue":"06","key":"ref117","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3109\/00365529509089793","article-title":"Fibrinolytic split products, fibrinolysis, and factor XIII activity in inflammatory bowel disease","volume":"30","author":"A A Van Bodegraven","year":"1995","journal-title":"Scand J Gastroenterol"},{"issue":"03","key":"ref118","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/00042737-200203000-00008","article-title":"Coagulation factor XIII and markers of thrombin generation and fibrinolysis in patients with inflammatory bowel disease","volume":"14","author":"M Hayat","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"03","key":"ref119","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1023\/A:1005680022573","article-title":"Serum transglutaminase correlates with endoscopic and histopathologic grading in patients with ulcerative colitis","volume":"46","author":"G D'Argenio","year":"2001","journal-title":"Dig Dis Sci"},{"issue":"06","key":"ref120","first-page":"690","article-title":"Factor XIII subunits in relation to some other hemostatic parameters in ulcerative colitis","volume":"86","author":"A Stadnicki","year":"1991","journal-title":"Am J Gastroenterol"},{"issue":"01","key":"ref121","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/gut.34.1.75","article-title":"Factor XIIIA subunit and Crohn's disease","volume":"34","author":"M Hudson","year":"1993","journal-title":"Gut"},{"issue":"06","key":"ref122","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000201166","article-title":"Ulcerative colitis and Crohn's disease: factor XIII, inflammation and haemostasis","volume":"55","author":"R Seitz","year":"1994","journal-title":"Digestion"},{"issue":"02","key":"ref123","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0005-2795(69)90277-3","article-title":"The effect of proteolytic enzymes on fibrin stabilizing factor","volume":"181","author":"M Kope\u0107","year":"1969","journal-title":"Biochim Biophys Acta"},{"issue":"02","key":"ref124","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1160\/TH07-02-0098","article-title":"Down-regulation of activated factor XIII by polymorphonuclear granulocyte proteases within fibrin clot","volume":"98","author":"Z Bagoly","year":"2007","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref125","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/BF00320061","article-title":"Dynamics of blood coagulation factor XIII in ulcerative colitis and preliminary study of the factor XIII concentrate","volume":"59","author":"R Suzuki","year":"1989","journal-title":"Blut"},{"issue":"05","key":"ref126","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1055\/s-2007-999045","article-title":"Factor XIII in chronic inflammatory bowel diseases","volume":"22","author":"R Lorenz","year":"1996","journal-title":"Semin Thromb Hemost"},{"issue":"03","key":"ref127","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0090-3019(00)00308-6","article-title":"Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures","volume":"54","author":"R Gerlach","year":"2000","journal-title":"Surg Neurol"},{"issue":"07","key":"ref128","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1460-9592.2011.03709.x","article-title":"Perioperative course of FXIII in children undergoing major surgery","volume":"22","author":"T Haas","year":"2012","journal-title":"Paediatr Anaesth"},{"issue":"08","key":"ref129","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/MBC.0000000000000953","article-title":"Nonimmune-acquired factor XIII deficiency: a cause of high volume and delayed postoperative hemorrhage","volume":"31","author":"F A Chuliber","year":"2020","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"05","key":"ref130","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.injury.2022.12.021","article-title":"Acquired factor XIII deficiency in patients with multiple trauma","volume":"54","author":"M Hetz","year":"2023","journal-title":"Injury"},{"issue":"02","key":"ref131","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2185\/jrm.2023-028","article-title":"Changes in coagulation factor XIII activity during resuscitation for hemorrhagic shock","volume":"19","author":"Y Yamada","year":"2024","journal-title":"J Rural Med"},{"issue":"01","key":"ref132","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/jca.21840","article-title":"Acquired factor XIII deficiency in patients under therapeutic plasma exchange: a poorly explored etiology","volume":"36","author":"F A Chuliber","year":"2021","journal-title":"J Clin Apher"},{"issue":"02","key":"ref133","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.transci.2013.06.004","article-title":"The effect of different apheresis modalities on coagulation factor XIII level during antibody removal in ABO-blood type incompatible living related renal transplantation","volume":"49","author":"N Hanafusa","year":"2013","journal-title":"Transfus Apher Sci"},{"issue":"03","key":"ref134","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0022-5223(94)70253-5","article-title":"Low factor XIIIA levels are associated with increased blood loss after coronary artery bypass grafting","volume":"108","author":"J R Shainoff","year":"1994","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"12","key":"ref135","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.3390\/jcm12124115","article-title":"Acquired factor XIII deficiency is common during ECMO therapy and associated with major bleeding events and transfusion requirements","volume":"12","author":"M Noitz","year":"2023","journal-title":"J Clin Med"},{"issue":"06","key":"ref136","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3390\/jcm10061203","article-title":"Factor XIII activity might already be impaired before veno-venous ECMO in ARDS patients: a prospective, observational single-center cohort study","volume":"10","author":"O Moerer","year":"2021","journal-title":"J Clin Med"},{"issue":"08","key":"ref137","first-page":"520","article-title":"[Factor XIII deficiency in burns]","volume":"48","author":"H Burkhardt","year":"1977","journal-title":"Chirurg"},{"issue":"07","key":"ref138","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.burns.2024.05.002","article-title":"Factor XIII in major burns coagulation","volume":"50","author":"P Guilabert","year":"2024","journal-title":"Burns"},{"issue":"06","key":"ref139","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s12185-012-1191-x","article-title":"Hemorrhagic-acquired factor XIII deficiency associated with tocilizumab for treatment of rheumatoid arthritis","volume":"96","author":"M Matsuoka","year":"2012","journal-title":"Int J Hematol"},{"issue":"08","key":"ref140","doi-asserted-by":"crossref","first-page":"e69944","DOI":"10.1371\/journal.pone.0069944","article-title":"Tocilizumab induced acquired factor XIII deficiency in patients with rheumatoid arthritis","volume":"8","author":"S Mokuda","year":"2013","journal-title":"PLoS One"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.thromres.2016.02.026","article-title":"Non-autoimmune combined factor XIII A and B subunit deficiencies in rheumatoid arthritis patients treated with anti-interleukin-6 receptor monoclonal antibody (tocilizumab)","volume":"140","author":"M Souri","year":"2016","journal-title":"Thromb Res"},{"key":"ref142","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pediatrneurol.2019.04.019","article-title":"Valproic acid-induced coagulopathy","volume":"98","author":"R Kumar","year":"2019","journal-title":"Pediatr Neurol"},{"issue":"02","key":"ref143","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1034\/j.1600-0404.2003.00149.x","article-title":"Valproate induces reversible factor XIII deficiency with risk of perioperative bleeding","volume":"108","author":"B Pohlmann-Eden","year":"2003","journal-title":"Acta Neurol Scand"},{"issue":"02","key":"ref144","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.0013-9580.2004.28302.x","article-title":"Factor XIII deficiency associated with valproate treatment","volume":"45","author":"M Teich","year":"2004","journal-title":"Epilepsia"},{"issue":"05","key":"ref145","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/MBC.0b013e3282f3f9ec","article-title":"High incidence of vaproate-induced coagulation disorders in children receiving valproic acid: a prospective study","volume":"19","author":"S Koenig","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"06","key":"ref146","doi-asserted-by":"crossref","first-page":"102903","DOI":"10.1016\/j.transci.2020.102903","article-title":"Acquired FXIII deficiency and AL amyloidosis: a case of a rare association","volume":"59","author":"A Ferretti","year":"2020","journal-title":"Transfus Apher Sci"},{"issue":"05","key":"ref147","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/MBC.0000000000001311","article-title":"Acquired factor XIII deficiency and its unprecedented association with multiple myeloma: case report and literature review","volume":"35","author":"B Trabelsi","year":"2024","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref148","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.thromres.2023.12.004","article-title":"Low factor XIII levels and altered fibrinolysis in patients with multiple myeloma","volume":"234","author":"H Ghansah","year":"2024","journal-title":"Thromb Res"},{"issue":"12","key":"ref149","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1055\/a-1450-8414","article-title":"COVID-19 is associated with an acquired factor XIII deficiency","volume":"121","author":"F A von Meijenfeldt","year":"2021","journal-title":"Thromb Haemost"},{"issue":"33","key":"ref150","doi-asserted-by":"crossref","first-page":"8656","DOI":"10.1021\/bi8006143","article-title":"Sushi domains in the B subunit of factor XIII responsible for oligomer assembly","volume":"47","author":"M Souri","year":"2008","journal-title":"Biochemistry"},{"issue":"02","key":"ref151","first-page":"275","volume":"25","author":"A Ichinose","year":"2014","journal-title":"Jap J Thromb Hemost"}],"container-title":["Seminars in Thrombosis and Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2633-0027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:02:40Z","timestamp":1773100960000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2633-0027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":150,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2026,3,9]]},"published-print":{"date-parts":[[2026,4]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2633-0027","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0094-6176","1098-9064"],"issn-type":[{"value":"0094-6176","type":"print"},{"value":"1098-9064","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6,12]]},"published":{"date-parts":[[2025,6,12]]}}}